Laffer Investments Stake In Amgen INC (AMGN) Was Increased

May 16, 2018 - By Jason Dias

Amgen Inc. (NASDAQ:AMGN) Corporate LogoBig Money Sentiment increased to 1.22 in Q4 2017. It has change of 0.23, from 2017Q3’s 0.99. The ratio improved due to AMGN positioning: 73 sold and 458 reduced. 122 funds took positions and 527 increased positions. Investors holded 555.05 million in 2017Q3 but now own 551.71 million shares or 0.60% less. Legacy Capital Prns Incorporated holds 0.35% in Amgen Inc. (NASDAQ:AMGN) or 4,100 shs. Stevens First Principles Investment Advsrs has invested 0.06% in Amgen Inc. (NASDAQ:AMGN). Moreover, Teachers Retirement Sys Of The State Of Kentucky has 0.61% invested in Amgen Inc. (NASDAQ:AMGN) for 297,427 shs. Shelton Cap Management holds 94,776 shs. Moreover, Winslow Asset Mngmt Inc has 0.28% invested in Amgen Inc. (NASDAQ:AMGN). Ibm Retirement Fund holds 18,148 shs. Commerzbank Aktiengesellschaft Fi has invested 0.24% of its capital in Amgen Inc. (NASDAQ:AMGN). 17,875 are held by Financial Bank Of The West. Creative Planning accumulated 0.07% or 96,307 shs. Van Hulzen Asset Lc has 0.36% invested in Amgen Inc. (NASDAQ:AMGN) for 6,786 shs. Cue Financial Group reported 0.75% in Amgen Inc. (NASDAQ:AMGN). Employees Retirement System Of Texas has invested 0.39% in Amgen Inc. (NASDAQ:AMGN). Pennsylvania-based Wheatland Advsr Inc has invested 0.44% in Amgen Inc. (NASDAQ:AMGN). Cohen Klingenstein Limited reported 0.82% stake. Avalon Advsrs Ltd Liability holds 0.74% of its capital in Amgen Inc. (NASDAQ:AMGN) for 138,445 shs.

AMGN had 5 sales and 0 insider buys since December 12, 2017. This’s net activity of $1.37 million.

According to 2017Q4 SEC form the Laffer Investments increased its stake in Amgen Inc (AMGN) by 60.06%. The company’s stock sank 2.99% while Laffer Investments bought 1,555 shares. At the end of 2017Q4, the 4,144 shares of the biological products (no diagnostic substances) company held by the institutional investor were priced at $720.64M, up from 2,589 at the end of the previous reported quarter. $115.75B is the market cap of Amgen Inc. Ticker’s shares touched $173.8 during the last trading session after 1.63% change.Currently Amgen Inc. is uptrending after 3.78% change in last May 16, 2017. AMGN has 2.13M shares volume. AMGN underperformed the S&P 500 by 7.77%.

Laffer Investments manages about $614.32 million and $399.05 billion US Long portfolio. It reduced its stake in Macquarie Infrastructure Corp (NYSE:MIC) by 762 shares to 8,929 shares, valued at $573.24M in 2017Q4, according to the filing. For a total of 18,808 shares it reduced its holding in Ishares Msci Singapore Capped Etf by 543 shares in the quarter, and has cut its stake in Boeing Co (NYSE:BA).

Another two news for Amgen Inc. (NASDAQ:AMGN) were briefly posted by: on May 16, 2018 with title “Expanded label for Amgen’s Repatha approved in Europe”. The other‘s article was titled “Better Buy: Amgen Inc. vs. Biogen Inc.” and posted on May 15, 2018.

Amgen Inc. (NASDAQ:AMGN) Ratings Coverage

Total analysts of 14 have positions in Amgen Inc (NASDAQ:AMGN) as follows: 7 rated it a “Buy”, 0 with “Sell” and 7 with “Hold”. The positive are 50%. Since December 15, 2017 according to StockzIntelligence Inc Amgen Inc has 17 analyst reports. The stock rating was maintained by Mizuho with “Buy” on Monday, February 12. On Tuesday, January 23 the stock of Amgen Inc. (NASDAQ:AMGN) earned “Buy” rating by Argus Research. The stock rating was maintained by Morgan Stanley with “Overweight” on Friday, February 2. On Friday, February 2 the firm has “Neutral” rating by Credit Suisse given. On Thursday, April 5 the stock of Amgen Inc. (NASDAQ:AMGN) earned “Equal-Weight” rating by Barclays Capital. In Monday, February 5 report Atlantic Securities downgraded the stock to “Hold” rating. On Wednesday, April 25 Morgan Stanley maintained Amgen Inc. (NASDAQ:AMGN) rating. Morgan Stanley has “Overweight” rating and $200 target. In Thursday, February 1 report Cowen & Co maintained it with “Buy” rating and $204.0 target. In Monday, January 22 report RBC Capital Markets maintained it with “Hold” rating and $189.0 target. In Thursday, January 18 report Piper Jaffray maintained it with “Buy” rating and $194.0 target.

Amgen Inc. (NASDAQ:AMGN) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: